Not only being one of the most cyclical, but also most hated energy sub-sectors, offshore drilling has been a secure investment grave for the last nearly 15 years. There is barely any investment topic where you could have sunk money more reliably. However, there are really interesting developments that make it worthwhile to risk a look into it, again. Especially, as along as it is perceived a no-go area for ESG-promoters – although offshore drilling tends to be the best choice in this regard.
Continue readingCategory Archives: investment climate / big picture
Earnings quality the worst in three decades – look at free cash flow!
Operating or net income, adjusted operating or net income, earnings per share (EPS), adjusted EPS and the price to earnings (PE) ratio are commonly used to assess a company’s business results and to value it. They are also often used as headline numbers and proof of performance by the companies themselves. However, there is a rising trend of decreasing “earnings quality” – an indicator that neither the economy is doing pretty well, nor many companies.
Continue readingIs the stock of M&T Bank the best pick among regional US-banks?
After the first wave of banking collapses last March and some subsequent calming down, the last few weeks have again been dominated by fears about who’s next. The California based First Republic Bank was the next to fall. Its assets were sold to JPMorgan. Stocks of other regional banks got hammered by even 50% in single trading days, as if this were nothing unusual. The search for the next victim is running. M&T Bank so far held up rather well (and managed to stay under the radar). Is it worth a closer look?
Continue readingGerman Conglomerates: Creating Shareholder Value from spin-offs? + new research report
Decades ago, it was en vogue to create big conglomerates. Size was associated with being a sign of strength, bringing robustness in times of economic distress. However, as “holding discounts” nowadays are holding these companies back from achieving higher valuations, the opposite direction is pursued to lift these “hidden values”. Many German concerns are currently in this process. There is also one particular under the radar opportunity that is too cheap to be ignored.
Continue readingUS shale production is peaking – what it means for oil and gas prices
You can read everywhere that due to the “coming recession” in Western countries, energy demand is going to take a hit and push prices down. Likewise, you also find headlines that Chinese recovery demand might come in below expectations. It is a foregone conclusion that prices of energy will go down – everything circles around demand. But is this the big picture? What would happen if a massive supply shock took market participants by surprise? You won’t be surprised, but prepared, with this latest Weekly.
Continue readingA company uranium investors should be monitoring closely
The investment thesis and the soil for expected higher uranium prices is based on a growing supply and demand imbalance. This is what I already wrote about. An underinvested, not growing supply base is facing higher, maybe even way higher demand from existing as well as new nuclear reactors that are under construction. Today, I am discussing the biggest uranium project under development.
Continue readingCommodity stocks and recessions – clearing up a common misconception
As many commodity prices – being economically sensitive resources – have dropped massively over the last months (and even more so over the last weeks) as well as a recession being expected by the consensus, the question is whether equities of commodity producers in general are about to crash. At least this was the procedure during the last Great Recession of 2008–2009. However, this is too simplified, completely ignoring history.
Continue readingWhat you should know about the SVB collapse – my premium members were warned
As I am publishing this Weekly, already a week has passed after the collapse of not just one bank dealing with startups – that was the 16th largest bank in the US – but indeed three banks. After emotions calmed down a bit, we can have a look at what went wrong and what you should be aware of. My Premium Members already knew about the risks “hidden” on the balance sheets of banks, as I’ve closed an investment case on a profit a month ago due to these risks. And no, this is not a buy-the-dip occasion!
Continue readingBig Pharma to destroy shareholder value? + new research report for Premium Members
Stocks of big pharmaceutical companies have been core holdings in many portfolios for as long as I can remember, probably even beyond that. The reasons are crystal-clear: an ever aging population, more chronic diseases also among younger generations, stable to slightly rising demand throughout the business cycle, relative price stability of those stocks and reliable dividends. What’s not to like?
Continue readingMegatrend of this decade: Dividend cuts + an update to my most popular article so far
Even though I know that I certainly won’t make many new friends with this article, especially not from the ranks of dividend investors, it is a duty for me to address this topic. I also think, it’s no coincidence that my most popular article to date has been about looming dividend cuts. Simply put, it’s too important to be ignored.
Continue reading